Samaha Eli
SEC Form 4 insider trading activity
Samaha Eli has filed 8 SEC Form 4 filings (11 transaction rows) across 2 companies, including STGW, TBPH, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Oct 2, 2026.
On the most recent filing, Samaha Eli is listed as 10% Owner at Theravance Biopharma, Inc. Inside the rolling window, Samaha Eli reported no open-market purchases and 5 open-market sales totaling $5.9M in TBPH. The largest disclosed transaction in the window is a sale of 273,871 TBPH shares on Jun 29, 2026, worth $4.7M.
Companies traded
Other insiders at STGW
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$5.9M
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Samaha Eli made?
Samaha Eli has filed 8 SEC Form 4 filings (11 transaction rows) across 2 companies, including STGW, TBPH since 2025.
Which companies does Samaha Eli trade?
Samaha Eli has filed SEC Form 4 disclosures for 2 companies, including STGW, TBPH.
When was Samaha Eli's most recent SEC Form 4 filing?
Samaha Eli's most recent SEC Form 4 filing on Tracefour is dated Oct 2, 2026.
What is Samaha Eli's total buy and sell value in the current window?
Inside the rolling retention window, Samaha Eli bought $0 and sold $5.9M based on SEC Form 4 filings.
What was Samaha Eli's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 273,871 TBPH shares on 2026-06-29, worth $4.7M, per SEC Form 4 filings.